Clinical Research Associate
Alexion
Clinical Research Associate
Alexion
Global biopharmaceuticals focusing on rare diseases
Contract Term: 1 year 6 months
This is what you will do:
You will be responsible for:
You will need to have:
We would prefer for you to have:
※ 채용 절차법에 따른 고지 사항
1. 제출한 서류는 채용 절차법에 따라, 일체 반환 의무가 없습니다.
2. 보훈대상자 및 취업보호대상자는 관련법에 의거하여 우대합니다.
3. 해외 여행 결격사유가 없어야 합니다.
4. 본 채용은 수시진행으로, 우수인력 채용 시 마감될 수 있습니다.
Date Posted
13-11월-2026Closing Date
07-1월-2027Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion